Solution formulation for continuous flow peritoneal dialysis.
Diaz-Buxo
José A
JA
Fresenius Medical Care, Lexington, Mass., USA. jose.diaz-buxo@fmc-na.com
D001639:Bicarbonates / Q000493:pharmacokinetics / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical; D015314:Dialysis Solutions / Q000493:pharmacokinetics / Q000494:pharmacology*; D005947:Glucose / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D009994:Osmolar Concentration; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods*; D011188:Potassium / Q000493:pharmacokinetics / Q000494:pharmacology; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012964:Sodium / Q000493:pharmacokinetics / Q000494:pharmacology
D001639:Bicarbonates; D015314:Dialysis Solutions; D012964:Sodium; D005947:Glucose; D011188:Potassium